logo

Myos Corp (MYOS)



Trade MYOS now with
  Date
  Headline
8/6/2019 9:04:21 PM MYOS RENS Technology Q2 Net Revenues Increased $66, Or 75%, To $154K
5/8/2019 6:01:08 PM MYOS RENS Technology Q1 Loss/share $0.13 Vs. Loss $0.19 Year Ago
4/4/2019 5:46:06 AM MYOS RENS Technology Signs Distribution Agreement With National Sales Associates
3/28/2019 6:05:57 AM MYOS RENS Technology Q4 Net Sales For The Quarter Ended December 31, 2018 Were $149k, Decrease Of 5%
1/15/2019 7:07:46 AM MYOS RENS Technology Announces Positive Top-line Results From Placebo-controlled Study Evaluating Fortetropin
1/3/2019 6:09:24 AM MYOS RENS Technology Receives New Patent From The United States Patent And Trademark Office
12/14/2018 6:06:15 AM MYOS RENS Technology CEO Joseph Mannello Issues Letter To Shareholders
12/6/2018 6:11:11 AM MYOS RENS Technology Announces Approval Of $1.2 Mln In NJEDA NOL Program Tax Credits
11/8/2018 6:15:21 AM MYOS RENS Technology Signs Distribution Agreement With Miller Veterinary Supply East
10/2/2018 6:13:06 AM Centers For Medicare And Medicaid Services Approves Reimbursement For Fortetropin-Based Enteral Nutrition Formula
6/6/2018 6:13:21 AM MYOS RENS Technology Announces Launch Of 'MYOS Canine Muscle Formula'
3/27/2018 5:59:49 PM MYOS RENS Technology Q4 Net Loss $1.08 Mln Vs. $752K Year Ago
  
 
>